Printer Friendly

CORDIS REPORTS SHARPLY HIGHER FIRST QUARTER RESULTS

 CORDIS REPORTS SHARPLY HIGHER FIRST QUARTER RESULTS
 MIAMI, Oct. 21 /PRNewswire/ -- Cordis Corporation (NASDAQ-NMS:


CORD), a Miami-based manufacturer of angiographic and neuroscience products, today reported a 27 percent jump in first-quarter earnings on a 25 percent increase in sales.
 For the three months ended Sept. 30, revenues, which benefited by currency gains, increased to $62.5 million from $50.1 million in the corresponding quarter a year ago. Angiography sales, which accounted for 94 percent of the total, advanced 26 percent; neuroscience revenues were up 4 percent.
 Net income rose to $6.1 million, or 42 cents a share, from $4.8 million, or 33 cents a share, in the year-earlier period.
 Speaking at the Dain Bosworth Health Care Conference in Minneapolis, Robert C. Strauss, president and chief executive officer, said that "the results reflect improvements in all segments of the company's business, including an encouraging pick-up in angioplasty sales. The performance was all the more impressive given higher costs, production interruptions and broad-based general distractions caused by Hurricane Andrew, which hit Miami in late August."
 Shares of Cordis are traded on the NASDAQ National Market under the symbol CORD.
 CORDIS CORPORATION
 Condensed Statements of Operations
 Three Months Ended Sept. 30, 1992 and 1991
 (unaudited)
 (dollars in thousands except per share amounts)
 1992 1991
 Net sales $62,515 $50,129
 Income before income taxes $ 8,840 $ 6,615
 Provision for income taxes 2,786 1,844
 Net income $ 6,054 $ 4,771
 Earnings per share $ 0.42 $ 0.33
 Weighted average shares
 outstanding 14,417,000 14,363,000
 -0- 10/21/92
 /CONTACT: Chick McDowell, vice president-corporate relations and assistant secretary of Cordis Corporation, 305-824-2821/
 (CORD) CO: Cordis Corporation ST: Florida IN: MTC SU: ERN


SS-JB -- FL002 -- 2693 10/21/92 08:58 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 21, 1992
Words:295
Previous Article:POLYGRAM FILMED ENTERTAINMENT ENTERS THREE-YEAR PACT WITH FOSTER
Next Article:SUNBEAM-OSTER REPORTS STRONG THIRD QUARTER: SALES UP 11 PERCENT AND EPS GROWS 27 PERCENT
Topics:


Related Articles
CORDIS REPORTS IMPROVED SECOND-QUARTER SALES AND EARNINGS
CORDIS REPORTS RECORD FISCAL 1992 RESULTS
CORDIS' SECOND QUARTER EARNINGS UP 24 PERCENT
CORDIS' THIRD QUARTER NET INCOME UP 19 PERCENT
CORDIS REPORTS RECORD QUARTER, FISCAL 1993 RESULTS
CORDIS REPORTS STRONG FIRST QUARTER RESULTS; CONTRIBUTION FROM ANGIOPLASTY PRODUCTS CITED
CORDIS REPORTS SHARPLY HIGHER SALES AND EARNINGS
CORDIS REPORTS RECORD SALES AND IMPROVED EARNINGS FOR QUARTER, FISCAL 1994
CORDIS REPORTS SHARPLY IMPROVED FIRST-QUARTER RESULTS
TARGET THERAPEUTICS ANNOUNCES SECOND QUARTER RESULTS; REVENUES INCREASE 36%; OPERATING INCOME INCREASES 54%

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters